Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Johnson & Johnson About to Put Its Talc Lawsuits to Bed?


Johnson & Johnson (NYSE: JNJ) has been dealing with tens of thousands of lawsuits related to its talc products, which plaintiffs allege gave them cancer. There is nothing unusual about a company the size of Johnson & Johnson dealing with some legal issues.

But the sheer number and nature of the company's lawsuits, combined with some plaintiffs accusing the drugmaker of knowing the dangers associated with its talc products but ignoring them to make a buck, have been damaging to the company's image.

Fortunately, Johnson & Johnson seems to be moving closer to putting this major risk in the rearview mirror. Let's discuss what that could mean for investors.

Continue reading


Source Fool.com

Like: 0
JNJ
Share

Comments